Home/SEngine Precision Medicine/Carla Grandori, MD, PhD
CG

Carla Grandori, MD, PhD

Co-Founder & CEO

SEngine Precision Medicine

Therapeutic Areas

SEngine Precision Medicine Pipeline

DrugIndicationPhase
PARIS® TestSolid Tumors (e.g., Ovarian, Colorectal, Breast)Commercial (LDT)